Back to search

Article

Graphene Family in the Acute Treatment of Migraine: Molecular Docking and Dynamics Simulation

2022-10-25

Abstract excerpt

At present, the FDA approved some drugs for treating migraines such as Ubrogepant and Rimegepant by targeting the calcitonin-gene-related peptide receptor (CGRPR). Although nanomaterials have been recognized as useful as drug carriers or therapeutics for other diseases, there are few studies on migraine. Here, we study the graphene nanosheets with various functional groups including –COOH, -NH 2 , –COOH-NH 2 , -OH...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ad8bceb-a937-54c9-a079-76341c4d1f9b
DOI
10.21203/rs.3.rs-2169537/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Graphene Family in the Acute Treatment of Migraine: Molecular Docking and Dynamics SimulationDOI 10.21203/rs.3.rs-2169537/v1
Molecular simulations reveal the impact of RAMP1 on ligand binding and dynamics of CGRPR heterodimerSemantic proximity
An insight into the activation mechanism of the calcitonin-gene-related peptide receptorSemantic proximity
Investigation of the activation mechanism and structural characterization of the CGRP receptorSemantic proximity
Recent advance in graphene-based two-dimensional nanomaterial assembly for advanced healthSemantic proximity
Effect of the Graphene Nanosheet on Bio-Functions of the Spike Protein at Open and Closed States: The Comparison Between SARS-CoV-2 WT and Omicron VariantSemantic proximity
Cryo‐EM structure of orphan G protein‐coupled receptor GPR21Semantic proximity
A novel plasma membrane-phillic graphene oxide nanocarrier for neuropeptide delivery to generate tolerogenic dendritic cells in GVHD ImmunotherapySemantic proximity
Ellagic Acid as a Natural Product-Based GPR35 Agonist for Ulcerative ColitisSemantic proximity
Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.Semantic proximity
CGRP Signals from Endosomes of Schwann Cells to Elicit Migraine PainSemantic proximity
Cryo-EM complex structure of active GPR75 with a nanobodySemantic proximity
Effect of Calcitonin Gene-Related Peptide Receptor Antagonists on Migraine Treatment: A Meta-AnalysisSemantic proximity
Select a neighboring publication to make it the new centre.